Overview

Study of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular Degeneration

Status:
Unknown status

Trial end date:
2011-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether microplasmin given by intravitreal injection is effective and safe for the treatment of wet age-related macular degeneration (AMD) in patients who have focal vitreomacular adhesion (VMA)

Phase:

Phase 2

Details

Lead Sponsor:

University of California, Los Angeles

Collaborator:

ThromboGenics

Treatments:

Fibrinolysin
Plasminogen